NCI Centers Of Nanotechnology Excellence To Be In Place Next Summer
This article was originally published in The Pink Sheet Daily
Five-year, $90 mil. funding stream for centers makes up the bulk of a $144.3 mil. initiative to advance research into nanotech and cancer. Training, grant-making and standardization efforts also are planned. FDA is collaborating on the National Cancer Institute program.
You may also be interested in...
VaxGen receives $877.5 mil. contract to supply 75 mil. doses of its recombinant protective antigen anthrax vaccine to the national stockpile within three years. The contract is contingent upon FDA clearing the vaccine for use under emergency conditions.
Program aimed at speeding Alzheimer’s drug development through neuroimaging and biomarkers is launched by the National Institute on Aging through a five-year, $60 mil. project. Large pharma companies are contributing funds to a multi-site study of 800 subjects.
A National Institutes of Health review has found only a small number of consulting relationships between researchers and pharmaceutical companies, NIH Deputy Director Kington says. The new policy must be approved by the White House.